Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery

被引：13
|
作者：
Litwinowicz, Radoslaw [1 ]
Konstanty-Kalandyk, Janusz [1 ,2 ]
Goralczyk, Tadeusz [3 ]
Bartus, Krzysztof [1 ,2 ]
Mazur, Piotr [1 ,2 ]
机构：
[1] John Paul 2 Hosp, Dept Cardiovasc Surg & Transplantol, Krakow, Poland
[2] Jagiellonian Univ, Inst Cardiol, Med Coll, 80 Pradnicka St, PL-31202 Krakow, Poland
[3] John Paul 2 Hosp, Cent Lab, Krakow, Poland
来源：
JOURNAL OF THROMBOSIS AND THROMBOLYSIS | 2018年 / 45卷 / 01期
关键词：
ANTAGONIST ORAL ANTICOAGULANTS; ATRIAL-FIBRILLATION; REVERSAL; MANAGEMENT; WARFARIN;
D O I：
10.1007/s11239-017-1587-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：9 / 12
页数：4
相关论文
共 50 条
  • [1] Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery
    Radoslaw Litwinowicz
    Janusz Konstanty-Kalandyk
    Tadeusz Goralczyk
    Krzysztof Bartus
    Piotr Mazur
    Journal of Thrombosis and Thrombolysis, 2018, 45 : 9 - 12
  • [2] Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures
    Vornicu, Ovidiu
    Larock, Anne-Sophie
    Dincq, Anne-Sophie
    Douxfils, Jonathan
    Dogne, Jean-Michel
    Mullier, Francois
    Lessire, Sarah
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (10) : 1275 - 1296
  • [3] Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery A Subanalysis of the RE-VERSE AD Study
    Levy, Jerrold H.
    van Ryn, Joanne
    Sellke, Frank W.
    Reilly, Paul A.
    Elsaesser, Amelie
    Glund, Stephan
    Kreuzer, Joerg
    Weitz, Jeffrey, I
    Pollack, Charles V., Jr.
    ANNALS OF SURGERY, 2021, 274 (03) : E204 - E211
  • [4] Pharmacokinetics of idarucizumab and its target dabigatran in patients requiring urgent reversal of the anticoagulant effect of dabigatran
    Glund, Stephan
    Coble, Kelly
    Gansser, Dietmar
    Stangier, Joachim
    Hoermann, Karin
    Pollack, Charles V.
    Reilly, Paul
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (08) : 1319 - 1328
  • [5] Idarucizumab for Reversal of Dabigatran Prior to Acute Surgery: A Schematic Approach Based on a Case Report
    Rosenberg, Lene
    Gerstrom, Gustav
    Nybo, Mads
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 120 (04) : 407 - 410
  • [6] Erroneous administration of the dabigatran antidote idarucizumab during surgery: case report and lessons learned
    Lavon, Ophir
    Musai, Yamit
    Shainer, Maayan
    Alroy-Preis, Sharon
    CLINICAL TOXICOLOGY, 2018, 56 (06) : 474 - 475
  • [7] Idarucizumab in Dabigatran-Treated Patients Requiring Emergency Surgery or Intervention: Updated/Final Results From the RE-VERSE AD Study
    Levy, Jerrold
    Sellke, Frank
    Reilly, Paul A.
    VanRyn, Joanne
    Kreuzer, Jorg
    Weitz, Jeffrey
    Pollack, Charles
    CIRCULATION, 2017, 136
  • [8] Use of idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. a multicentric experience in spain
    Crespo-Leiro, M. G. Maria G.
    Raquel Lopez-Vilella, R. L. V.
    Lopez Granados, A. L. G. Amador
    Mirabet-Perez, S.
    Diez-Lopez, C.
    Barge-Caballero, E.
    Segovia-Cubero, J.
    Gonzalez-Vilchez, F.
    Rangel-Sousa, D.
    Blasco-Peiro, T.
    De La Fuente-Galan, L.
    Diaz-Molina, B.
    Zatarain-Nicolas, E.
    Carrasco Avalos, F.
    Almenar-Bonet, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 76 - 77
  • [9] Use of Idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. A multicentric experience in Spain
    Crespo-Leiro, Maria G.
    Lopez-Vilella, Raquel
    Lopez Granados, Amador
    Mirabet-Perez, Sonia
    Diez-Lopez, Carles
    Barge-Caballero, Eduardo
    Segovia-Cubero, Javier
    Gonzalez-Vilchez, Francisco
    Rangel-Sousa, Diego
    Blasco-Peiro, Teresa
    de la Fuente-Galan, Luis
    Diaz-Molina, Beatriz
    Zatarain-Nicolas, Eduardo
    Carrasco Avalos, Francisco
    Almenar-Bonet, Luis
    CLINICAL TRANSPLANTATION, 2019, 33 (12)
  • [10] Initial experience with idarucizumab in dabigatran-treated patients requiring emergency surgery or interventon: interim results from the RE-VERSE AD study
    Levy, J. H.
    Verhamme, P.
    Sellke, F. W.
    Reilly, P. A.
    Dubiel, R.
    Eikelboom, J.
    Hylek, E.
    Kreuzer, J.
    Weitz, J. I.
    Pollack, C.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1043 - 1043
12345